Načítá se...
A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell Therapies
The treatment of B-cell malignancies by adoptive cell transfer (ACT) of anti-CD19 chimeric antigen receptor T cells (CD19 CAR-T) has proven to be a highly successful therapeutic modality in several clinical trials.(1–6) The anti-CD19 CAR-T cell production method used to support initial trials relied...
Uloženo v:
| Vydáno v: | Hum Gene Ther Methods |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mary Ann Liebert, Inc.
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6445175/ https://ncbi.nlm.nih.gov/pubmed/27897048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hgtb.2016.120 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|